US Stock MarketDetailed Quotes

RVMD Revolution Medicines

Watchlist
  • 44.120
  • +0.120+0.27%
Close Jan 3 16:00 ET
  • 44.120
  • 0.0000.00%
Post 16:20 ET
8.15BMarket Cap-12.05P/E (TTM)

About Revolution Medicines Company

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Company Profile

SymbolRVMD
Company NameRevolution Medicines
Listing DateFeb 13, 2020
Issue Price17.00
Founded2004
CEODr. Mark A. Goldsmith, M.D., PhD
MarketNASDAQ
Employees378
Fiscal Year Ends12-31
Address700 Saginaw Drive
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94063
Phone1-650-481-6801

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Mark A. Goldsmith, M.D., PhD
  • President, Chief Executive Officer and Chairman of the Board
  • 10.41M
  • Jack Anders
  • Chief Financial Officer and Principal Accounting Officer
  • 3.05M
  • Margaret A. Horn, J.D.
  • Chief Operating Officer
  • 4.39M
  • Dr. Wei Lin
  • Chief Medical Officer
  • --
  • Dr. Jing Yi, PhD
  • Senior Vice President, Head of Program Leadership.
  • --
  • Dr. Mary Pinder-Schenck, M.D.
  • Senior Vice President, Head of Medical Affairs
  • --
  • Xiaolin Wang
  • Executive Vice President, Development
  • 3.23M
  • Ryan Asay
  • Senior Vice President, Corporate Affairs
  • --
  • Dr. Mason Shih, M.D.
  • Senior Vice President, Head of Drug Safety
  • --
  • Jeff Cislini
  • Senior Vice President, General Counsel and Secretary
  • --
  • Dr. Stephen M. Kelsey, F.R.C.P.,M.D.
  • President, Research and Development
  • 4.39M
  • Elizabeth McKee Anderson, M.B.A.
  • Independent Director
  • 483.78K
  • Dr. Lorence H. Kim, M.D.
  • Independent Director
  • 489.99K
  • Dr. Flavia Borellini, PhD
  • Independent Director
  • 489.09K
  • Dr. Barbara L. Weber, M.D.
  • Independent Director
  • 480.19K
  • Frank K. Clyburn, Jr
  • Independent Director
  • --
  • Alexis A. Borisy, A.M.
  • Lead Independent Director
  • 510.63K
  • Dr. Sushil Patel, PhD
  • Independent Director
  • 475.19K
  • Dr. Thilo Schroeder, PhD
  • Independent Director
  • --
  • Dr. Sandra J. Horning, M.D.
  • Independent Director
  • 720.00K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.